ATE223914T1 - Trans apovincaminsäure-esterderivate als arzneimittel - Google Patents
Trans apovincaminsäure-esterderivate als arzneimittelInfo
- Publication number
- ATE223914T1 ATE223914T1 AT96942534T AT96942534T ATE223914T1 AT E223914 T1 ATE223914 T1 AT E223914T1 AT 96942534 T AT96942534 T AT 96942534T AT 96942534 T AT96942534 T AT 96942534T AT E223914 T1 ATE223914 T1 AT E223914T1
- Authority
- AT
- Austria
- Prior art keywords
- trans
- acid ester
- ester derivatives
- medicinal products
- apovincamic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9503736A HU214600B (hu) | 1995-12-22 | 1995-12-22 | Transz-apovinkaminsav-észter-származékok, az azokat tartalmazó gyógyszerkészítmények és eljárás ezek előállítására |
PCT/HU1996/000075 WO1997023481A1 (en) | 1995-12-22 | 1996-12-13 | Trans apovincaminic acid ester derivatives as drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE223914T1 true ATE223914T1 (de) | 2002-09-15 |
Family
ID=10987512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96942534T ATE223914T1 (de) | 1995-12-22 | 1996-12-13 | Trans apovincaminsäure-esterderivate als arzneimittel |
Country Status (22)
Country | Link |
---|---|
US (1) | US6093720A (de) |
EP (1) | EP0876367B1 (de) |
JP (1) | JP2000502676A (de) |
KR (1) | KR19990076606A (de) |
CN (1) | CN1072670C (de) |
AR (1) | AR005182A1 (de) |
AT (1) | ATE223914T1 (de) |
AU (1) | AU1166997A (de) |
CA (1) | CA2238635A1 (de) |
CZ (1) | CZ290383B6 (de) |
DE (1) | DE69623656T2 (de) |
DK (1) | DK0876367T3 (de) |
ES (1) | ES2181926T3 (de) |
HU (1) | HU214600B (de) |
IL (1) | IL124097A (de) |
PL (1) | PL186626B1 (de) |
PT (1) | PT876367E (de) |
RU (1) | RU2161157C2 (de) |
TW (1) | TW366348B (de) |
UA (1) | UA61062C2 (de) |
WO (1) | WO1997023481A1 (de) |
ZA (1) | ZA9610646B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006054536A1 (ja) * | 2004-11-16 | 2006-05-26 | Nippon Shinyaku Co., Ltd. | 尿路結石症治療剤 |
JP2008017734A (ja) * | 2006-07-11 | 2008-01-31 | Memory Secret Inc | 精神的機能を改善するための栄養補助及び栄養摂取食品用の口経投与組成物 |
CN102485723A (zh) * | 2010-12-02 | 2012-06-06 | 江苏斯威森生物医药工程研究中心有限公司 | 一锅法半合成长春西汀及其水溶性盐制备 |
CN114920743B (zh) * | 2022-05-09 | 2023-08-04 | 南京中医药大学 | 一种吲哚生物碱及其制备方法与应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2531108A1 (de) * | 1975-07-11 | 1977-02-03 | Synthelabo | Vincaminderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
HU186891B (en) * | 1981-06-12 | 1985-10-28 | Richter Gedeon Vegyeszet | Process for producing esters of apovincaminic acid |
IT1142026B (it) * | 1981-07-21 | 1986-10-08 | Ausonia Farma Srl | Nuovo composto ad attivita' eumetabolica cerebrale |
HU187733B (en) * | 1982-06-30 | 1986-02-28 | Richter Gedeon Vegyeszeti Gyar Rt,Hu | Process for preparing apovincaminic acid derivatives |
JPS60248688A (ja) * | 1984-05-24 | 1985-12-09 | Sanwa Kagaku Kenkyusho:Kk | 新規のアポビンカミン酸エステルおよびその酸付加塩並びにその製造方法 |
-
1995
- 1995-12-22 HU HU9503736A patent/HU214600B/hu not_active IP Right Cessation
-
1996
- 1996-12-13 US US09/091,260 patent/US6093720A/en not_active Expired - Fee Related
- 1996-12-13 WO PCT/HU1996/000075 patent/WO1997023481A1/en active IP Right Grant
- 1996-12-13 CA CA002238635A patent/CA2238635A1/en not_active Abandoned
- 1996-12-13 KR KR1019980704700A patent/KR19990076606A/ko active IP Right Grant
- 1996-12-13 DE DE69623656T patent/DE69623656T2/de not_active Expired - Fee Related
- 1996-12-13 IL IL12409796A patent/IL124097A/en not_active IP Right Cessation
- 1996-12-13 ES ES96942534T patent/ES2181926T3/es not_active Expired - Lifetime
- 1996-12-13 UA UA98052781A patent/UA61062C2/uk unknown
- 1996-12-13 PT PT96942534T patent/PT876367E/pt unknown
- 1996-12-13 CZ CZ19981962A patent/CZ290383B6/cs not_active IP Right Cessation
- 1996-12-13 DK DK96942534T patent/DK0876367T3/da active
- 1996-12-13 AT AT96942534T patent/ATE223914T1/de not_active IP Right Cessation
- 1996-12-13 PL PL96328170A patent/PL186626B1/pl not_active IP Right Cessation
- 1996-12-13 AU AU11669/97A patent/AU1166997A/en not_active Abandoned
- 1996-12-13 CN CN96199131A patent/CN1072670C/zh not_active Expired - Fee Related
- 1996-12-13 EP EP96942534A patent/EP0876367B1/de not_active Expired - Lifetime
- 1996-12-13 RU RU98113854/04A patent/RU2161157C2/ru not_active IP Right Cessation
- 1996-12-13 JP JP09523441A patent/JP2000502676A/ja not_active Withdrawn
- 1996-12-16 TW TW085115515A patent/TW366348B/zh active
- 1996-12-18 ZA ZA9610646A patent/ZA9610646B/xx unknown
- 1996-12-20 AR ARP960105829A patent/AR005182A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR19990076606A (ko) | 1999-10-15 |
CZ290383B6 (cs) | 2002-07-17 |
CN1205701A (zh) | 1999-01-20 |
TW366348B (en) | 1999-08-11 |
WO1997023481A1 (en) | 1997-07-03 |
HU214600B (hu) | 1998-04-28 |
US6093720A (en) | 2000-07-25 |
CA2238635A1 (en) | 1997-07-03 |
CZ196298A3 (cs) | 1998-10-14 |
IL124097A (en) | 2001-12-23 |
HU9503736D0 (en) | 1996-02-28 |
ES2181926T3 (es) | 2003-03-01 |
DE69623656T2 (de) | 2003-05-22 |
EP0876367B1 (de) | 2002-09-11 |
PL328170A1 (en) | 1999-01-18 |
EP0876367A1 (de) | 1998-11-11 |
PL186626B1 (pl) | 2004-02-27 |
UA61062C2 (en) | 2003-11-17 |
DE69623656D1 (en) | 2002-10-17 |
HUT76555A (en) | 1997-09-29 |
JP2000502676A (ja) | 2000-03-07 |
ZA9610646B (en) | 1997-06-24 |
AR005182A1 (es) | 1999-04-14 |
CN1072670C (zh) | 2001-10-10 |
AU1166997A (en) | 1997-07-17 |
RU2161157C2 (ru) | 2000-12-27 |
PT876367E (pt) | 2003-01-31 |
DK0876367T3 (da) | 2002-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE248594T1 (de) | Irbesartanhaltiges arzneimittel | |
ATE219089T1 (de) | Triazol-derivate als arzneimittel | |
BR9610153A (pt) | Formulações farmacêuticas | |
BR9611626A (pt) | Formulações farmacéuticas | |
ATE211131T1 (de) | Arylsulfonylaminohydroxamsäurederivate | |
NO20021172L (no) | Farmasöytisk sammensetning | |
BR9611367A (pt) | Formulação farmacêutic liofilizada estável | |
NO961136D0 (no) | Farmasöytisk formuleringsgrunnlag for nano-suspensjoner | |
BR9610396A (pt) | Formulação farmacêutica | |
ATE255117T1 (de) | Aminophosphonsäure-derivate als arzneimittel | |
DE69600081D1 (de) | Selbstbräunende kosmetische Mittel | |
IS4774A (is) | Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum | |
HUP9801156A3 (en) | Carbapenem-3-carboxylic acid ester derivatives | |
DK0925273T3 (da) | Farmaceutiske præparater indeholdende 4-oxo-butansyrer | |
LV11727A (lv) | Farmaceitiska kompozicija | |
DK86492D0 (da) | Laegemiddel | |
ATE223914T1 (de) | Trans apovincaminsäure-esterderivate als arzneimittel | |
FI942581A (fi) | Menetelmä 5-bromi-6-metoksi-1-naftoehappometyyliesterin valmistamiseksi | |
FI973280A (fi) | Farmaseuttinen koostumus | |
FI973230A (fi) | Uusi farmaseuttinen formulaatio | |
DE59404990D1 (de) | Fettsäureester von Methylglucosid-Derivaten | |
ATE269337T1 (de) | Trizyclische delta3-pyridine als arzneimittel | |
ATE227295T1 (de) | Phosphin- und phosphonsäurederivate als arzneimittel | |
BR9610139A (pt) | Derivado de ácido carboxílico | |
BR9606066A (pt) | Composto e formulação farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |